Perispinal etanercept for neuroinflammatory disorders

Edward Tobinick1

  • 1Institute for Neurological Research, a private medical group, inc. 100 UCLA Medical Plaza, Suites 205-210, Los Angeles, CA 90095, United States. etmd@ucla.edu

Drug Discovery Today
|November 26, 2008
PubMed
Summary

Excess tumor necrosis factor (TNF) drives neuroinflammation in disorders like Alzheimer's disease. Perispinal etanercept rapidly improves symptoms by targeting TNF's role in synaptic function.